Goldman L., Caldera DL, Nussman SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med297:845, 1977
2.
Mangano DT, Browner WS, Hollenberg M., et al.Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing non-cardiac surgery: The Study of Perioperative Ischemia Research Group. N Engl J Med323:1781, 1990
3.
Mantha S., Roizen MF, Barnard J., et al. Relative effectiveness of four preoperative tests for predicting adverse cardiac outcomes after vascular surgery: a meta-analysis. Anesth Analg79:422, 1994
4.
Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: Report of the American College of Cardiology/ American Heart Association Task Force on Practical Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol27:910, 1996
5.
Leenen Fhh.Cardiovascular consequences of sympathetic hyperactivity. Can J Cardiol15:2A, 1999 (Suppl)
6.
Meredith IT, Broughton A., Jennings GL, et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med325:618, 1991
7.
Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation85:177, 1992 (Suppl)
8.
Reiter MJ, Reiffel JAImportance of beta-blockade in the therapy of serious ventricular arrhythmias . Am J Cardiol82:91, 1998
9.
Singh BNAntiarrhythmic drugs: Re-orientation of recent developments in the control of disorders of cardiac rhythm. Am J Cardiol81:3D, 1998
10.
Yusuf S., Peto R., Lewis J., et al. Beta-blockade during myocardial infarction: An overview of randomized trials. Prog Cardiovasc Dis27:335, 1985
11.
Yusuf S., Wittes J., Friedman L.Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA260:2088, 1988
12.
Hallstrom AP , Cobb LA, Yu BH, et al. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol68:1025, 1991
13.
Schwartz PJThe idiopathic long QT interval syndrome: Progress and questions. Am Heart J109:399, 1985
14.
Tan HL, Hou CJ, Lauer MR, et al. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Int Med122:701, 1995
15.
Steinbeck G. , Andersen D., Bach P., et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy to patients with symptomatic sustained tachyarrhythmias. N Engl J Med327:987, 1992
16.
Wiesfeld AC , Crijns HJ, Tuininga YS, et al. Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. Pacing & Clin Electrophysiol19:1026, 1996
17.
Multicentre international study: Supplementary report. Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Br Med J12:419, 1997.
18.
Beta-blocker Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA247:1707, 1982
19.
Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. The MIAMI Trial Research Group. Eur Heart J6:199, 1985
20.
ISIS-1 Collaborative Group.Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival). Lancet1:922, 1988
21.
Kendall MJ, Lynch KP, Hjalmarson A., et al. Beta-blockers and sudden cardiac death. Ann Intern Med123:358, 1995
22.
Hjalmarson A.Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol80:35J, 1997
23.
Avanzini F. , Zuanetti G., Latini R., et al. Use of beta-blocking agents in secondary prevention after myocardial infarction: A case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators. Eur Heart J18:1447, 1997
24.
Pfisterer M. , Cox JL, Granger CB, et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: The GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. J Am Coll Cardiol32:634, 1998
25.
Gottlieb SS , McCarter RJ, Vogel RAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction . N Engl J Med339:4889, 1998
26.
Chadda K., Goldstein S., Byington R., et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation73:5003, 1986
27.
Packer M., Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The Precise Trial. Circulation94:2793, 1996
28.
Packer M., Bristow MR, Cohn JNThe effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med334:1349, 1996
29.
Waagestein F., Bristow MR, Swedberg K., et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet342:1441, 1993
30.
CIBIS Investigators and Committees.A randomized trial of beta-blockade and heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation90:1765, 1994
31.
MERIT-HEFT Study Group.Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet353:2001, 1999
32.
CIBIS-II Investigators and Committees.The cardiac insufficiency treated with bisoprolol. CIBIS II). Lancet353:9, 1999
33.
Australia-New Zealand Heart Failure Research Collaborative Group.Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet349:375, 1997
34.
Australia-New Zealand Heart Failure Research Collaborative Group.Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation92:212, 1995
35.
Stone JG, Foex P., Sear JW, et al. Myocardial ischemia in untreated hypertensive patients: Effect of a single small dose of beta-adrenergic blocking agent. Anesthesiology68:495, 1988
36.
Pasternack PF, Imparato AM, Baumann FG, et al. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation76:III-1-III-7, 1987 (Suppl)
37.
Pasternack PF, Grossi EA, Baumann FG, et al. Beta-blockade to decrease silent myocardial ischemia during peripheral vascular surgery . Am J Surg158:113, 1989
38.
Poldermans D., Boersma E., Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med341:1789, 1999
39.
Lee THReducing cardiac risk in noncardiac surgery. N Engl J Med341:1838-1839, 1999
40.
Poldermans D., Arnese M., Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography . J Am Coll Cardiol26:648, 1995
41.
Davila-Roman VG, Waggoner AD, Sicard GA, et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol21:957, 1993
42.
Mangano DT, Browner WS, Hollenberg M., et al. Association of perioperative myocardial ischemia with morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med323:1781, 1990
Mangano DT, Layug EL, Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med335:1713, 1996
45.
First International Study of Infarct Survival Collaborative Group.Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infraction: ISIS-1. Lancet2:57, 1986
46.
Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: The Atenolol Silent Ischemia Study. Circulation90:762, 1994.
47.
Wallace A., Layug B., Tateo I., et al. Prophylactic atenolol reduced post-operative myocardial ischemia . Anesthesiology88:17, 1998
48.
Singh BN, Lopez B., Sarma Jsm.Significance and prevention of atrial fibrillation occurring after cardiac surgery: A time for fundamental change in strategy? J CardioscPharmacol Therapeut3:259, 1998
